Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Sanjivani Paranteral Ltd

NSE: SANJIVIN · BSE: 531569 · Pharmaceuticals & Biotechnology · 25 announcements

Share price
₹176.50
Market cap
₹216.8 Cr
Revenue (annual)
₹68.67 Cr
Net profit (annual)
₹6.79 Cr
P/E (TTM)
20.6×Sector 47.3×
Promoter holding
31.56%+0.30% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:24 IST BSE
Annual General Meeting

Sanjivani Paranteral Annual General Meeting

Sanjivani Paranteral Limited held its 32nd Annual General Meeting on September 16, 2026. The meeting concluded with resolutions on financial statements and director re-appointment.

15:04 IST BSE
Annual General Meeting

Sanjivani Paranteral Annual General Meeting

Sanjivani Paranteral shareholders approved the issuance of 5,00,000 convertible warrants to promoters on a preferential basis. A material related party transaction with subsidiary SPL Infusion was also cleared.

23:41 IST BSE
Annual General Meeting

Sanjivani Paranteral Annual General Meeting

Sanjivani Paranteral Ltd issued a Postal Ballot notice to seek shareholder approval for issuing 5,00,000 convertible warrants and approving material related party transactions worth ₹10 Crore.

Value
₹10.00 Cr
23:41 IST BSE
Annual General Meeting

Sanjivani Paranteral Annual General Meeting

Sanjivani Paranteral issued a postal ballot notice to seek shareholder approval for issuing 5,00,000 convertible warrants to its promoter, raising ₹7.37 Crore.

Value
₹7.37 Cr